Trial ID or NCT#
The maximum tolerated dose of 3-session (ie, treatment) stereotactic radiosurgery to treat brain metastases greater than 4.2 cm3 in size will be determined. This study investigates if increasing radiation dose improves outcome for patients without greater toxicity (side effects).
A Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Contact us to find out if this trial is right for you.